Pulmonary arterial hypertension trials recruiting in Ohio

All Pulmonary arterial hypertension trials nationally

Cities in Ohio

Recruiting trials in Ohio

• A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
  NCT07218029 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Cincinnati, Cleveland, Columbus
• An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
  NCT07365332 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Ohio: Cincinnati
• Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
  NCT06274801 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Ohio: Cincinnati
• Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
  NCT02249923 · Phase: Not specified · Ages: 1 Day to 21 Years · Sex: All (male and female) · Ohio: Cincinnati
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
  NCT04278404 · Phase: Not specified · Ages: 0 Years to 20 Years · Sex: All (male and female) · Ohio: Cincinnati
• Pulmonary Hypertension Association Registry
  NCT04071327 · Phase: Not specified · Ages: 0 Years and older · Sex: All (male and female) · Ohio: Cincinnati
• Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
  NCT05587712 · Phase: Phase 2 · Ages: 1 Year to 17 Years · Sex: All (male and female) · Ohio: Cincinnati
• Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
  NCT04555161 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Cincinnati, Columbus